TransMedics Group Inc (fra:8T8) Share Price

Company Profile

Business description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Contact
200 Minuteman Road
AndoverMA01810
USA
T: +1 978 552-0900
https://www.transmedics.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
728

Recommended

Rising inflation is the fly in the ointment.

Simonelle Mody | 08 January 2026

As we start the new year, let’s take a closer look at three compelling opportunities on the ASX

Tyger Fitzpatrick | 07 January 2026

Shares attractive due to near term profit margin increase and structural growth.

Johannes Faul, CFA | 07 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,046.50	22.30	0.25%
CAC 40	8,222.94	10.98	-0.13%
DAX 40	25,092.54	29.72	-0.12%
Dow JONES (US)	48,996.08	466.00	-0.94%
FTSE 100	10,031.52	16.69	-0.17%
HKSE	26,149.31	309.64	-1.17%
NASDAQ	23,584.28	37.10	0.16%
Nikkei 225	51,117.26	844.72	-1.63%
NZX 50 Index	13,716.86	1.84	0.01%
S&P 500	6,920.93	23.89	-0.34%
S&P/ASX 200	8,720.80	18.20	0.21%
SSE Composite Index	4,082.98	2.79	-0.07%